Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

How ‘killer’ T cells could boost COVID immunity in face of new variants

In the race against emerging coronavirus variants, researchers are looking beyond antibodies for clues to lasting protection from COVID-19.
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed  Google Scholar

Concerns about coronavirus variants that might be partially resistant to antibody defences have spurred renewed interest in other immune responses that protect against viruses. In particular, scientists are hopeful that T cells — a group of immune cells that can target and destroy virus-infected cells — could provide some immunity to COVID-19, even if antibodies become less effective at fighting the disease.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 590, 374-375 (2021)

doi: https://doi.org/10.1038/d41586-021-00367-7

References

  1. Tarke, A. et al. Cell Rep. Med. https://doi.org/10.1016/j.xcrm.2021.100204 (2021).

    Article  PubMed  Google Scholar 

  2. Skelly, D. T. et al. Preprint at https://www.researchsquare.com/article/rs-226857/v1 (2021).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links